Search clinical trials for: Pneumococcal Vaccine Formulation 1

Total 1129 results

Geisinger Clinic

Not yet recruiting

Pneumonia Vaccine Education Intervention Study (PVI)

Pneumonia, Pneumococcal | Vaccine
GlaxoSmithKline

Completed

Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children

Infections, Streptococcal

Czechia
Sanofi Pasteur, a Sanofi Company

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

France, Poland
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Splenic Marginal Zone Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Cutaneous B-cell Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Adult Grade III Lymphomatoid... and other conditions

United States
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Healthy

Singapore
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
National Institutes for Food and Drug Control, China; Simoon Record Pharma... and other collaborators

Unknown

Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months

Pneumonia, Pneumococcal

China
Merck Sharp & Dohme LLC

Completed

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Pneumococcal Infection
H. Lee Moffitt Cancer Center and Research Institute

Completed

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant (PCV13)

Multiple Myeloma

United States
Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants

Vaccines, Pneumococcal

United States
Ewha Womans University

Completed

Study of Evaluation Indexes for Antibody Production in Sera After Immunization

Aged

Korea, Republic of
CanSino Biologics Inc.

Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria

China
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children

Dengue Fever

Thailand
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects

Influenza

United Kingdom
China National Biotec Group Company Limited
Sichuan Center for Disease Control and Prevention

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of PPV23 Vaccine Revaccinations in the Elderly

Vaccination

China
Pfizer

Completed

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Pneumococcal Infections

Japan
GlaxoSmithKline

Completed

Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose

Infections, Streptococcal

Singapore
Aghia Sophia Children's Hospital of Athens

Unknown

Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules

Immunogenicity, Vaccine | Immunologic Memory

Greece
Pfizer

Completed

Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults

Pneumococcal Infections
Pfizer

Completed

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Safety | Immunization | 13-valent Pneumococcal Vaccine | Antibody Response

France
Wuhan BravoVax Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention; Liaoning Chengda...

Recruiting

Phase I Clinical Trial of a Candidate PCV13 in Healthy People

Pneumococcal Infections

China
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036) (PNEU-PED-KOR)

Pneumococcal Disease

Korea, Republic of
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Active, not recruiting

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Condylomata Acuminata
Pfizer

Completed

A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India

Pneumococcal Disease

India
China National Biotec Group Company Limited
Shanghai Municipal Center for Disease Control and Prevention

Completed

A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old

Vaccination

China
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

Pneumococcal Infections

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

Infections, Streptococcal

Germany
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Completed

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Pneumonia, Pneumococcal

China
GlaxoSmithKline

Completed

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

Infections, Streptococcal

Nigeria
Thomas Jefferson University

Completed

Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center (PPVP)

Study is Open to Seniors Age 50 or Older

United States
National Jewish Health

Unknown

Pneumococcal Post-Vaccination Titers

Smokers, Elderly, Asthma, COPD, Recurrent Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico

Vaccines, Pneumococcal

Mexico
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Safety and Local Tolerability of Prevenar in Indian Children

Pneumococcal Infections
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

Pneumococcal Infections
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028)

Pneumococcal Infections

Japan
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Chile
Novartis Vaccines
Novartis

Completed

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

Prevention of Meningococcal Disease

Canada, United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively (GRC00097)

Influenza

United States
GlaxoSmithKline
Kwame Nkrumah University of Science and Technology; European & Developing Countries... and other collaborators

Recruiting

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

Salmonella Infections

Ghana
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)

Influenza

United States
Vifor (International) Inc.

Completed

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Healthy

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

Pneumococcal Vaccines

Poland
Pfizer

Completed

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

HIV Infections | Pneumococcal Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)

Influenza

France
Pfizer

Completed

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Neisseria Meningitidis (Bacterial Meningitis) | Invasive Pneumococcal Disease (IPD)

Germany
Maria de Lourdes de Sousa Maia, MD

Not yet recruiting

Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil.

Pneumococcal Vaccines
University of Oxford
Johns Hopkins Bloomberg School of Public Health; University of Otago; Patan Academy...

Completed

PCV10 Immunogenicity Study Nepal 2015

Streptococcus Pneumoniae

United Kingdom
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Elderly

Infections, Streptococcal

Sweden
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
Pfizer

Completed

Prevenar13 Post Market Surveillance

Healthy

Korea, Republic of

3

Subscribe